Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Group 1 - Standard BioTools Inc. granted an equity award of 207,832 restricted stock units (RSUs) to a new employee as an inducement for employment, effective May 20, 2024 [1] - The RSUs will vest in a structured manner, with 1/4th vesting on May 20, 2025, and 1/16th vesting every three months thereafter, contingent on the employee's continued service [2] - Standard BioTools, formerly known as Fluidigm Corporation, specializes in next-generation technologies that aid biomedical researchers in developing medicines more efficiently [3] Group 2 - The company utilizes proprietary mass cytometry and microfluidics technologies to provide insights in health and disease, focusing on areas such as oncology, immunology, and immunotherapy [3] - Standard BioTools collaborates with various sectors, including academic, government, pharmaceutical, and clinical laboratories, to address critical needs in translational and clinical research [3]